Founded in Evanston, United States, Ohmx is a clinical diagnostic company dedicated to developing low-cost, bioelectronic Point-Of-Care (POC) systems. Their core mission is to enable quick, cost-effective diagnosis and monitoring of chronic diseases, particularly diabetes, through portable analyzers. These devices can quantify analytes from small biological samples such as whole blood, urine, and other fluids, making them ideal for use in physician office labs (POLs).
Ohmx has attracted notable investors and affiliations within the medical technology sector. The company has achieved significant milestones in creating efficient diagnostic tools that improve patient care and reduce healthcare costs. By focusing on chronic disease management, Ohmx has made a substantial impact on the medical diagnostics market, offering innovative solutions that enhance the capabilities of clinicians and improve patient outcomes.
